Role of Multifocal Visually Evoked Potential as a Biomarker of Demyelination, Spontaneous Remyelination, and Myelin Repair in Multiple Sclerosis.

Front Neurosci · 2021 · PMC8586643 · PMID 34776840

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

reached borderline significanceno p-value reported

In the RENEW study, both the conventional full-field VEP (which was the primary endpoint of the study) and the mfVEP latency demonstrated a larger improvement in ON eyes of patients treated with opicinumab compared to placebo ( Cadavid et al., 2017 ; Klistorner et al., 2018 ), although this only reached borderline significance.

also in 370 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.